| Serial Number | 98343321 |
| Word Mark | TEVOGEN.AI |
| Filing Date | Friday, January 5, 2024 |
| Status | 692 - WITHDRAWN BEFORE PUBLICATION |
| Status Date | Tuesday, October 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | TEVOGEN ARTIFICIAL INTELLIGENCE |
| Goods and Services | Promoting collaboration in the field of biotechnology to achieve innovation through increased usage of artificial intelligence (AI) technology; promoting the benefits of the use of artificial intelligence (AI) technology in the field of biotechnology to expedite drug development, optimize laboratory processes, unravel complex biological data, and improve patient outcomes; promotion and advocacy services, namely promoting the benefits of the advancement of biomedical, biotechnological, and immunological research and the curing of various diseases utilizing artificial intelligence (AI) technology, by means of public advocacy; promotion and advocacy services, namely, promoting the benefits of increasing the affordability of and increased access to medical services and the treatment of various diseases, as well as overall patient-centric medical services, utilizing artificial intelligence (AI) technology, by means of public advocacy; promotion and advocacy services, namely promoting the benefit of the treatment of various diseases using T cell therapies and artificial intelligence (AI) technology, by means of public advocacy; promoting collaboration within the scientific, research and medical provider communities to achieve advances in the fields of biotechnology, biomedicine, immunology, immunotherapies, and T-cell therapies utilizing artificial intelligence (AI) technology; business operations consulting in the fields of biotechnology and life sciences; business operations consulting in the fields of biotechnology and life sciences to increase business processes automation and increase the efficiency of business operations procedures; database management in the fields of biotechnology and life sciences; creation being compilation and systemization of information into databases and management of databases in the fields of biotechnology and life sciences; compilation of information into computer databases in the fields of biotechnology and life sciences; systematization of data through a medical device network for medical research purposes; business data analysis in the fields of biotechnology and life sciences; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business feasibility study planning, namely, for clinical trials; business study data interpretation, namely, for clinical trials; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval |
| Goods and Services | Providing a website featuring news and information concerning biotechnology, biomedicine, immunology, immunotherapies, and T-cell therapies that utilize artificial intelligence (AI) technology; providing news and information concerning the prevention and treatment of oncological diseases, autoimmune diseases, neurological diseases, viral infections, and COVID-19 using artificial intelligence (AI) enabled technology; providing information concerning use of T cells and other lymphocytes for the prevention and treatment of various diseases, as enhanced by artificial intelligence (AI) technology |
| Goods and Services | Providing a website featuring news and information concerning biomedical, biotechnological, and immunological research that utilizes artificial intelligence (AI) technology; providing news and information concerning biomedical, biotechnological, and immunological research that utilizes artificial intelligence (AI) technology; providing information concerning biomedical research into the efficacy of T cells and other lymphocytes for the prevention and treatment of various diseases, as enhanced by artificial intelligence (AI) technology; providing medical and scientific research information in the fields of T cell therapies, biologics, pharmaceuticals, and clinical trials that utilize artificial intelligence (AI) technology; providing a website featuring temporary access to non-downloadable computer software for expediting drug development, optimizing laboratory processes, and unravelling complex biological data; providing a website featuring temporary access to non-downloadable computer software for human leukocyte antigen (HLA) specificity mapping; providing a website featuring temporary access to non-downloadable computer software for protein sequencing and genome matching; hosting of non-downloadable computer software for clinical trial and patient information database management; providing online, non-downloadable computer software for machine learning and training of artificial intelligence models in the fields of biomedical, biotechnological, and immunological research; analysis of data from databases in the fields of biotechnology and life sciences; collection of data through a medical device network for medical research purposes; providing an internet-based database for business purposes designed to facilitate complex statistical techniques, programming technologies and validation procedures to support clinical trials containing clinical trial data |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 5, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 5, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 5, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tevogen Bio Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Metuchen, NJ 08840 |
| Event Date | Event Description |
| Friday, January 5, 2024 | NEW APPLICATION ENTERED |
| Monday, April 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 1, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, August 6, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 6, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 6, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 1, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 1, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, October 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 1, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, October 1, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 22, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |